Literature DB >> 22993066

The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo.

Antje Pöschke1, Niklas Kern, Takayuki Maruyama, Hermann Pavenstädt, Shuh Narumiya, Boye L Jensen, Rolf M Nüsing.   

Abstract

Increased cyclooxygenase-2 (COX-2) expression and PGE(2) synthesis have been shown to be prerequisites for renal renin release after Na(+) deprivation. To answer the question of whether EP4 receptor type of PGE(2) mediates renin regulation under a low-salt diet, we examined renin regulation in EP4(+/+), EP4(-/-), and in wild-type mice treated with EP4 receptor antagonist. After 2 wk of a low-salt diet (0.02% wt/wt NaCl), EP4(+/+) mice showed diminished Na(+) excretion, unchanged K(+) excretion, and reduced Ca(2+) excretion. Diuresis and plasma electrolytes remained unchanged. EP4(-/-) exhibited a similar attenuation of Na(+) excretion; however, diuresis and K(+) excretion were enhanced, and plasma Na(+) concentration was higher, whereas plasma K(+) concentration was lower compared with control diet. There were no significant differences between EP4(+/+) and EP4(-/-) mice in blood pressure, creatinine clearance, and plasma antidiuretic hormone (ADH) concentration. Following salt restriction, plasma renin and aldosterone concentrations and kidney renin mRNA level rose significantly in EP4(+/+) but not in EP4(-/-) and in wild-type mice treated with EP4 antagonist ONO-AE3-208. In the latter two groups, the low-salt diet caused a significantly greater rise in PGE(2) excretion. Furthermore, mRNA expression for COX-2 and PGE(2) synthetic activity was significantly greater in EP4(-/-) than in EP4(+/+) mice. We conclude that low dietary salt intake induces expression of COX-2 followed by enhanced renal PGE(2) synthesis, which stimulates the renin-angiotensin-aldosterone system by activation of EP4 receptor. Most likely, defects at the step of EP4 receptor block negative feedback mechanisms on the renal COX system, leading to persistently high PGE(2) levels, diuresis, and K(+) loss.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993066     DOI: 10.1152/ajprenal.00512.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

Review 1.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.

Authors:  Tianxin Yang; Chuanming Xu
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

3.  Prorenin Receptor, a Necessary Component in Urine Concentration Mechanism.

Authors:  Boye L Jensen
Journal:  J Am Soc Nephrol       Date:  2016-04-20       Impact factor: 10.121

4.  Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.

Authors:  Kazuhiko Mizukami; Hiroyuki Yoshida; Eisuke Nozawa; Koichi Wada; Tohru Ugawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-15       Impact factor: 3.000

5.  PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.

Authors:  Rania Nasrallah; Joseph Zimpelmann; David Eckert; Jamie Ghossein; Sean Geddes; Jean-Claude Beique; Jean-Francois Thibodeau; Chris R J Kennedy; Kevin D Burns; Richard L Hébert
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

Review 6.  Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.

Authors:  Lu Wang; Yiqian Wu; Zhanjun Jia; Jing Yu; Songming Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

7.  Na+-Retaining Action of COX-2 (Cyclooxygenase-2)/EP1 Pathway in the Collecting Duct via Activation of Intrarenal Renin-Angiotensin-Aldosterone System and Epithelial Sodium Channel.

Authors:  Chuanming Xu; Guangrui Yang; Ziwei Fu; Yanting Chen; Shiying Xie; Fei Wang; Tianxin Yang
Journal:  Hypertension       Date:  2022-03-17       Impact factor: 9.897

Review 8.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

Review 9.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

10.  Group V Secretory Phospholipase A2 Is Involved in Tubular Integrity and Sodium Handling in the Kidney.

Authors:  João Luiz Silva-Filho; Diogo Barros Peruchetti; Felipe Moraes-Santos; Sharon Schilling Landgraf; Leandro Souza Silva; Gabriela Modenesi Sirtoli; Daniel Zamith-Miranda; Christina Maeda Takiya; Ana Acacia Sá Pinheiro; Bruno Lourenço Diaz; Celso Caruso-Neves
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.